# Treatment for Early Memory Loss

> **NCT00042172** · PHASE4 · COMPLETED · sponsor: **University of Iowa** · enrollment: 40 (—)

## Conditions studied

- Cognition Disorders
- Alzheimer Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Ginkgo Biloba Extract

## Key facts

- **NCT ID:** NCT00042172
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2014-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042172, "Treatment for Early Memory Loss". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00042172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*